Prestige Consumer Healthcare
251 hedge funds and large institutions have $2.75B invested in Prestige Consumer Healthcare in 2017 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 98 increasing their positions, 83 reducing their positions, and 32 closing their positions.
117% more call options, than puts
Call options by funds: $2.89M | Put options by funds: $1.33M
41% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 32
18% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 83
7.5% more ownership
Funds ownership: 109.87% → 117.37% (+7.5%)
5% more funds holding
Funds holding: 239 → 251 (+12)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less capital invested
Capital invested by funds: $2.92B → $2.75B (-$163M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$44.3M |
| 2 |
JP Morgan Chase
New York
|
+$31.3M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$24M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$22.5M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$17.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$38.9M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$35.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$22.9M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$11M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$7.09M |
PBH Hedge Fund Activity: Q4 2017 in Review
251 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q4 2017, worth a combined $2.75B — down 5.6% from $2.92B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new PBH positions and 32 closed out — a net gain of 13 holders — while 98 added to existing stakes and 83 trimmed.
The largest buyer was Wells Fargo, adding an estimated $44.3M. The largest seller was BlackRock, cutting an estimated $38.9M.
- 251 institutional investors held Prestige Consumer Healthcare (PBH) as of Q4 2017, up from 239 in Q3 2017.
- Funds reported $2.75B of Prestige Consumer Healthcare stock for Q4 2017, down 5.6% quarter-over-quarter.
- 45 funds opened new Prestige Consumer Healthcare positions in Q4 2017 and 32 closed out, a net change of +13 holders.
- The largest Prestige Consumer Healthcare buyer in Q4 2017 was Wells Fargo, an estimated $44.3M added.
- The largest Prestige Consumer Healthcare seller in Q4 2017 was BlackRock, an estimated $38.9M sold.
Based on aggregated 13F filings for Q4 2017.